Modern Rheumatology

Article	Citations
The 2020 revised comprehensive diagnostic (RCD) criteria for IgG4-RD	226
Anifrolumab, a monoclonal antibody to the type I interferon receptor subunit 1, for the treatment of systemic lupus erythematosus: an overview from clinical trials	54
Real-world treatment of gout and asymptomatic hyperuricemia: A cross-sectional study of Japanese health insurance claims data	40
Drug treatment algorithm and recommendations from the 2020 update of the Japan College of Rheumatology clinical practice guidelines for the management of rheumatoid arthritis—secondary publication	39
A review of upadacitinib in rheumatoid arthritis	36
Which is the best SLE activity index for clinical trials?	24
Depression, physical function, and disease activity associated with frailty in patients with rheumatoid arthritis	23
Association of methotrexate use and lymphoproliferative disorder in patients with rheumatoid arthritis: Results from a Japanese multi-institutional retrospective study	21
Long-term outcomes of refractory Takayasu arteritis patients treated with biologics including ustekinumab	20
Progressive fibrosing interstitial lung diseases: A new concept and indication of nintedanib	20
Filgotinib, a novel JAK1-preferential inhibitor for the treatment of rheumatoid arthritis: An overview from clinical trials	20
Treatment strategies for elderly-onset rheumatoid arthritis in the new era	19
Clinical features of elderly-onset Adult-onset Still’s disease	17
Clinicopathological characteristics of lymphoproliferative disorders in 232 patients with rheumatoid arthritis in Japan: A retrospective, multicenter, descriptive study	16
The effect of gender on disease activity and clinical characteristics in patients with axial psoriatic arthritis	15
Characteristics of rheumatoid arthritis with immunodeficiency-associated lymphoproliferative disorders to regress spontaneously by the withdrawal of methotrexate and their clinical course: A retrospec	15
Does exercise therapy improve patient-reported outcomes in rheumatoid arthritis? A systematic review and meta-analysis for the update of the 2020 JCR guidelines for the management of rheumatoid arthri	14
Efficacy and safety of canakinumab in systemic juvenile idiopathic arthritis: 48-week results from an open-label phase III study in Japanese patients	14
Antiphospholipid antibodies in COVID-19-associated pneumonia patients in intensive care unit	13
Comparable efficacy of denosumab and romosozumab in patients with rheumatoid arthritis receiving glucocorticoid administration	12
Effects of follow-on therapy after denosumab discontinuation in patients with postmenopausal osteoporosis	12
Efficacy and safety of the anti-TNF multivalent NANOBODY® compound ozoralizumab in patients with rheumatoid arthritis and an inadequate response to methotrexate: A 52-week result of a Phase II/III stu	12
Tofacitinib in interstitial lung disease complicated with anti-MDA5 antibody-positive dermatomyositis: A literature review	12
Systematic review and meta-analysis of biosimilar for the treatment of rheumatoid arthritis informing the 2020 update of the Japan College of Rheumatology clinical practice guidelines for the manageme	12
Efficacy and safety of apremilast for 3 months in Behçet’s disease: A prospective observational study	11

Prevalence and clinical association with calcinosis cutis in early systemic sclerosis	11
Chronic postsurgical pain after total knee arthroplasty: A prospective cohort study in Japanese population	11
Efficacy and safety of anti-TNF multivalent NANOBODY® compound ‘ozoralizumab’ without methotrexate co-administration in patients with active rheumatoid arthritis: A 52-week result of phase III, random	11
A phase 2 study of E6011, an anti-Fractalkine monoclonal antibody, in patients with rheumatoid arthritis inadequately responding to biological disease-modifying antirheumatic drugs	11
Effects of brief self-exercise education on the management of chronic low back pain: A community-based, randomized, parallel-group pragmatic trial	11
SAPHO syndrome and pustulotic arthro-osteitis	11
Efficacy and safety of filgotinib in combination with methotrexate in Japanese patients with active rheumatoid arthritis who have an inadequate response to methotrexate: Subpopulation analyses of 24-w	10
Avacopan, a selective C5a receptor antagonist, for anti-neutrophil cytoplasmic antibody-associated vasculitis	10
Should we reconsider the definition of elderly-onset rheumatoid arthritis in an ageing society?	10
Complexity of enthesitis and new bone formation in ankylosing spondylitis: current understanding of the immunopathology and therapeutic approaches	10
Evaluation of changes in oral health-related quality of life over time in patients with Sjögren’s syndrome	10
COVID-19 in patients with Behçet’s disease: Outcomes and rate of Behçet’s exacerbations in a retrospective cohort	10
Comprehensive review on intravertebral intraspinal, intrajoint, and intradiscal vacuum phenomenon: From anatomy and physiology to pathology	10
Non-radiographic axial spondyloarthritis	9
Potential of the prognostic nutritional index to determine the risk factor for severe infection in elderly patients with rheumatoid arthritis	9
Interluekin-6 inhibitors for the treatment of adult-onset Still’s disease	9
The involvement of leucine-rich α-2 glycoprotein in the progression of skin and lung fibrosis in bleomycin-induced systemic sclerosis model	9
Central sensitization in axial spondyloarthritis: An explorative study with quantitative sensory testing and clinical scales	9
Macrophage activation syndrome in patients with adult-onset Still’s disease under tocilizumab treatment: A single-center observational study	9
Lupus manifestations in children with primary immunodeficiency diseases: Comprehensive phenotypic and genetic features and outcome	9
Safety and effectiveness of baricitinib for rheumatoid arthritis in Japanese clinical practice: 24-week results of all-case post-marketing surveillance	9
Efficacy and safety of avacopan in Japanese patients with antineutrophil cytoplasmic antibody-associated vasculitis: A subanalysis of a randomized Phase 3 study	9
Predictors of long-term therapy with glucocorticoid in polymyalgia rheumatica	9
Pool-based exercise for amelioration of pain in adults with fibromyalgia syndrome: A systematic review and meta-analysis	9
Subcutaneous injection of methotrexate: Advantages in the treatment of rheumatoid arthritis	8
Iguratimod treatment reduces disease activity in early primary Sjögren's syndrome: An open-label pilot study	8
Management of sarcopenia in patients with rheumatoid arthritis	8
Annual variation rate of KL-6 for predicting acute exacerbation in patients with rheumatoid arthritis-associated interstitial lung disease	8
Role of dietary patterns and factors in determining the risk of knee osteoarthritis: A meta-analysis	8
How should rheumatologists manage glucocorticoid-induced hyperglycemia?	8
Antibody response to SARS-CoV-2 mRNA vaccines in patients with rheumatic diseases in Japan: Interim analysis of a multicentre cohort study	8
Low-dose mepolizumab is effective as an add-on therapy for treating long-lasting peripheral neuropathy in patients with eosinophilic granulomatosis with polyangiitis	8
Epidemiological study of osteonecrosis of the femoral head using the national registry of designated intractable diseases in Japan	8
Distinct clinical characteristics of pediatric Behçet’s syndrome: A study from a referral center in China	8
Clinical phenotypes and genetic analyses for diagnosis of systemic autoinflammatory diseases in adult patients with unexplained fever	8
Systematic review for the treatment of older rheumatoid arthritis patients informing the 2020 update of the Japan College of Rheumatology clinical practice guidelines for the management of rheumatoid	8
Clinical practice guidance for Sjögren’s syndrome in pediatric patients (2018) – summarized and updated	8
Efficacy and safety of sodium RISedronate for glucocorticoid-induced OsTeoporosis with rheumaTOid arthritis (RISOTTO study): A multicentre, double-blind, randomized, placebo-controlled trial	8
The prevalence and impact of sarcopenia in females undergoing total hip arthroplasty: A prospective study	8
The relationship between platelet to albumin ratio and disease activity in axial spondyloarthritis patients	8
Severe joint deformity and patient global assessment of disease are associated with discrepancies between sonographic and clinical remission: A cross-sectional study of rheumatoid arthritis patients	8
Pyroptosis inhibition alleviates potassium oxonate- and monosodium urate-induced gouty arthritis in mice	8
Trend in prescription and treatment retention of molecular-targeted drugs in 121,131 Japanese patients with rheumatoid arthritis: A population-based real-world study	8
Long-term safety and effectiveness of mycophenolate mofetil in adults with lupus nephritis: a real-world study in Japan	7
Kynurenine pathway of tryptophan metabolism in patients with familial Mediterranean fever	7
QTc interval prolongation in patients with systemic lupus erythematosus treated with hydroxychloroquine	7
Clinical profile and outcome of large-vessel giant cell arteritis in Japanese patients: A single-centre retrospective cohort study	7
Recent advances in IgG4-related kidney disease	7
The prevalence, burden of disease, and healthcare utilization of patients with eosinophilic granulomatosis with polyangiitis in Japan: a retrospective, descriptive cohort claims database study	7
A pooled safety analysis of peficitinib (ASP015K) in Asian patients with rheumatoid arthritis treated over a median of 2 years	7

Evaluation of the Central Sensitization Inventory Score in elderly adults with musculoskeletal examination	7
Prevention of bone loss and improvement of pain-related behavior in hind limb-unloaded mice by administration of teriparatide and bisphosphonate	7
Risk factors of postoperative delayed wound healing in patients with rheumatoid arthritis treated with a biological agent	7
The impact of coexisting fibromyalgia syndrome on disease activity in patients with psoriatic arthritis and rheumatoid arthritis: A cross-sectional study	7
Effectiveness and safety of infliximab dose escalation in patients with refractory Takayasu arteritis: A real-life experience from a monocentric cohort	7
The role of ultrasound and FDG-PET/CT to detect extracranial artery involvement in patients with suspected large vessel vasculitis	7
Clinical features and prognosis of nocardiosis in patients with connective tissue diseases	7
Glucocorticoids in the treatment of IgG4-related disease—Prospects for new international treatment guidelines	7
Efficacy and safety of filgotinib in Japanese patients with refractory rheumatoid arthritis: Subgroup analyses of a global phase 3 study (FINCH 2)	6
Assessment of discordance of treatment satisfaction between patients with rheumatoid arthritis in low disease activity or in remission and their treating physicians: A cross-sectional survey	6
Three-year results of denosumab treatment for osteoporosis in women with rheumatoid arthritis and primary osteoporosis: A clinical observational study	6
Rituximab in the real-world treatment of lupus nephritis: A retrospective cohort study in Japan	6
Comparison of therapeutic effects of combination therapy with prednisolone and tacrolimus or azathioprine on progressive interstitial pneumonia with systemic sclerosis	6
Automatic quantification and grading of hip bone marrow oedema in ankylosing spondylitis based on deep learning	6
The efficacy and safety of reduced-dose sulfamethoxazole-trimethoprim for chemoprophylaxis of Pneumocystis pneumonia in patients with rheumatic diseases	6
Urticaria and increased risk of rheumatoid arthritis: a two-sample Mendelian randomisation study in European population	6
Real-world safety and efficacy of CT-P13, an infliximab biosimilar, in Japanese rheumatoid arthritis patients naïve to or switched from biologics	6
Foot orthosis treatment improves physical activity but not muscle quantity in patients with concurrent rheumatoid arthritis and sarcopenia	6
Fifteen-year trends in the number and age of patients with rheumatoid arthritis undergoing total knee and hip arthroplasty: A comparison study with osteoarthritis	6
Questionnaire survey on transitional care for patients with juvenile idiopathic arthritis (JIA) and families	6
Efficacy and safety of peficitinib in rheumatoid arthritis	6
A multicentre, large-scale, observational study of tocilizumab in patients with Takayasu arteritis in Japan: The ACTEMRA® (ACT)-Bridge study	6
Usefulness of ultrasound as a predictor of elderly-onset rheumatoid arthritis with polymyalgia rheumatica-like onset	6
A nationwide questionnaire survey on the prevalence of ankylosing spondylitis and non-radiographic axial spondyloarthritis in Japan	6
Initial predictors of skin thickness progression in patients with diffuse cutaneous systemic sclerosis: Results from a multicentre prospective cohort in Japan	6
Clinical features and outcomes of childhood polyarteritis nodosa: A single referral center experience	6
Central sensitization and its relationship with health profile in Behçet’s disease	6
Association between low back pain and quality of life in patients with rheumatoid arthritis according to patient-reported outcomes using the Japanese Orthopaedic Association Back Pain Evaluation Quest	6
Population-based prevalence of femoroacetabular impingement in Japan	6
Long-term outcome and predictors of remission in Behçet’s disease in daily practice	6
Interferons and systemic lupus erythematosus: Pathogenesis, clinical features, and treatments in interferon-driven disease	6
Nation-wide survey of the treatment trend of microscopic polyangiitis and granulomatosis with polyangiitis in Japan using the Japanese Ministry of Health, Labour and Welfare Database	6
B-Cell depletion therapy in IgG4-related disease: State of the art and future perspectives	6
Differences in sex- and age-associated mortality in patients with anti-MDA5-positive dermatomyositis	6
Patients’ perspectives of rheumatoid arthritis treatment: a questionnaire survey for the 2020 update of the Japan college of rheumatology clinical practice guidelines	6
Relationship between locomotive syndrome and frailty in rheumatoid arthritis patients by locomotive syndrome stage	5
Differences of 2-year longitudinal changes of locomotive syndrome among patients treated with thoracolumbar interbody fusion, total hip arthroplasty, and total knee arthroplasty for degenerative disea	5
Cost-effectiveness analyses of biologic and targeted synthetic disease-modifying anti-rheumatic diseases in patients with rheumatoid arthritis: Three approaches with a cohort simulation and real-world	5
Establishing clinical remission criteria and the framework of a treat-to-target algorithm for Takayasu arteritis: Results of a Delphi exercise carried out by an expert panel of the Japan Research Comm	5
Effectiveness of combination tocilizumab and glucocorticoids as an induction therapy in patients with Takayasu arteritis: An observational study	5
miR-144-3p aggravated cartilage injury in rheumatoid arthritis by regulating BMP2/PI3K/Akt axis	5
Development and validation of a quality of life scale in Familial Mediterranean Fever (FMFQoL)	5
Lower CH50 as a predictor for intractable or recurrent lupus enteritis: A retrospective observational study	5
Perspectives on current and emerging therapies for immunoglobulin G4–related disease	5
Serum protein levels of YKL-40 and plasma miR-214 expression in patients with systemic sclerosis	5
Beneficial effects of apremilast on genital ulcers, skin lesions, and arthritis in patients with Behçet’s disease: A systematic review and meta-analysis	5
Deep learning methods in the diagnosis of sacroiliitis from plain pelvic radiographs	5
MicroRNA-106b overexpression suppresses synovial inflammation and alleviates synovial damage in patients with rheumatoid arthritis	5
The risk factors and incidence of major infectious diseases in patients with ankylosing spondylitis receiving tumor necrosis factor inhibitors	5
Validation of new ACR/EULAR 2022 classification criteria for anti-neutrophil cytoplasmic antibody–associated vasculitis	5
Good response to methotrexate is associated with a decrease in the gene expression of ABCG2, a drug transporter, in patients with rheumatoid arthritis	5
Comparison of romosozumab versus denosumab treatment on bone mineral density after 1 year in rheumatoid arthritis patients with severe osteoporosis: A randomized clinical pilot study	5
Upadacitinib monotherapy versus methotrexate monotherapy in methotrexate-naïve Japanese patients with rheumatoid arthritis: a sub-analysis of the Phase 3 SELECT-EARLY study	5
Predictors of persistent inflammation in children with familial Mediterranean fever	5
A multianalyte assay for the detection of dermatomyositis-related autoantibodies based on immunoprecipitation combined with immunoblotting	5
Have the radiographic characteristics of total knee arthroplasty recipients in rheumatoid arthritis changed after the induction of biologic disease modifying antirheumatic drugs?	5
Effectiveness and safety of subcutaneous abatacept in biologic-naïve RA patients at Week 52: A Japanese multicentre investigational study (ORIGAMI study)	5
Trends in risks of malignancies in Japanese patients with rheumatoid arthritis: Analyses from a 14-year observation of the IORRA cohort	5
Performance of recent PRINTO criteria versus current ILAR criteria for systemic juvenile idiopathic arthritis: A single-centre experience	5
Treatment of rheumatoid arthritis after regression of lymphoproliferative disorders in patients treated with methotrexate: a retrospective, multi-center descriptive study	5
Ultrasound assessment of sarcopenia in patients with rheumatoid arthritis	5
Apremilast in a Japanese subgroup with Behçet’s syndrome: Results from a Phase 3, randomised, double-blind, placebo-controlled study	5
Japan College of Rheumatology guidance for the use of methotrexate in patients with rheumatoid arthritis: Secondary publication	5
Evaluation of retinal vascularization by optical coherence tomography angiography (OCTA) in rheumatoid arthritis, and its relationship with disease activity	5
Changes in treatment adherence and behaviour during the COVID-19 pandemic in Japanese patients with rheumatoid arthritis: Results from cross-sectional study in the IORRA cohort	5
Comprehensive risk analysis of postoperative complications in patients with rheumatoid arthritis for the 2020 update of the Japan College of Rheumatology clinical practice guidelines for the managemen	5
Evaluation of vitamin D profile in juvenile idiopathic arthritis	4
Is musculoskeletal pain related to locomotive syndrome even in young and middle-aged adults?	4
High plasma homocysteine level is associated with increased prevalence of the non-remission state in rheumatoid arthritis: Findings from the KURAMA cohort	4
Rheumatoid arthritis with nontuberculous mycobacterial pulmonary disease: a retrospective, single-centre cohort study	4
Anti-Ro/SS-A antibody is associated with worse pulmonary outcome and reduced overall survival in systemic sclerosis	4
Treatment patterns and health care resource utilization among Japanese patients with ankylosing spondylitis: A hospital claims database analysis	4
Predictors of infliximab refractory intestinal Behçet’s syndrome: A retrospective cohort study from the Shanghai Behçet’s syndrome database	4
Status of fracture risk assessment and osteoporosis treatment in Japanese patients with rheumatoid arthritis	4
Clinical significance of HScore and MS score comparison in the prognostic evaluation of anti-MDA5-positive patients with dermatomyositis and interstitial lung disease	4
HR-pQCT in vivo imaging of periarticular bone changes in chronic inflammatory diseases: Data from acquisition to impact on treatment indications	4
Ultrasonography of IgG4-related dacryoadenitis and sialadenitis: Imaging features and clinical usefulness	4
Non-drug and surgical treatment algorithm and recommendations for the 2020 update of the Japan College of Rheumatology clinical practice guidelines for the management of rheumatoid arthritis—secondary	4
Drug efficacy and safety of biologics and Janus kinase inhibitors in elderly patients with rheumatoid arthritis	4
The real-world effectiveness of anti-RANKL antibody denosumab on the clinical fracture prevention in patients with rheumatoid arthritis: The ANSWER cohort study	4

The immune dysregulations in COVID-19: Implications for the management of rheumatic diseases	4
Prevalence of anti-cyclic citrullinated peptide antibodies in patients with spondyloarthritis: A retrospective study	4
JKAP serves as a potential biomarker for the evaluation of inflammatory condition, disease activity, and treatment response to TNF inhibitor in ankylosing spondylitis patients	4
Long-term safety and efficacy of E6011, an anti-fractalkine monoclonal antibody, in patients with rheumatoid arthritis inadequately responding to methotrexate	4
Polypharmacy, declined walking speed, bent back, and disability associated with a history of falls in Japanese patients with rheumatoid arthritis: Results from the IORRA cohort study	4
Clinical characteristics and social productivity levels of patients with malignant rheumatoid arthritis based on a nationwide clinical database in Japan: annual survey from 2003 to 2013	4
Effect of administration of immunoglobulin preparations on the results of tests for autoantibodies	4
Detection of nerve enlargement with ultrasound and correlation with skin biopsy findings in painful sensory neuropathy associated with Sjögren’s syndrome	4
Minimum 10 years clinical results of an anatomical short stem with a proximal hydroxyapatite coating	4
Global research trends in hyperuricemia: a bibliometric and visualized study	4
Mast cells can produce transforming growth factor β1 and promote tissue fibrosis during the development of Sjögren’s syndrome-related sialadenitis	4
Symptoms compatible with Rome IV functional bowel disorder in patients with ankylosing spondylitis	4
Phenotypic landscape of systemic lupus erythematosus: An analysis of the Kyoto Lupus Cohort	4
Vitamin D receptor expression in SLE peripheral blood CD4+T cells is associated with disease activity and cell apoptosis	4
The effect of parity, history of preeclampsia, and pregnancy care on the incidence of subsequent preeclampsia in multiparous women with SLE	4
Evaluation of quality and reliability of musculoskeletal ultrasound videos on YouTube	4
Geographic distribution of the incidence of osteonecrosis of the femoral head in Japan and its relation to smoking prevalence	4
Improvement of locomotive syndrome after total hip arthroplasty: A two-year longitudinal cohort study	4
Effect of hydroxychloroquine on angiographic progression in routine treatment of Takayasu arteritis	4
Comparison of physical activity levels among different sub-types of axial spondyloarthritis patients and healthy controls	4
Rituximab maintenance therapy for patients with antineutrophil cytoplasmic antibody-associated vasculitis in Japan	4
Simplified disease activity index and clinical disease activity index before and during pregnancy correlate with those at postpartum in patients with rheumatoid arthritis	4
What is the impact of methotrexate on liver in patients with juvenile idiopathic arthritis? Results of liver SWE performed in a single centre	4
Risk of herpes zoster in patients with rheumatoid arthritis in the biologics era from 2011 to 2015 and its association with methotrexate, biologics, and corticosteroids	4
Differences in knee joint degeneration between primary hip osteoarthritis and hip osteoarthritis secondary to hip developmental dysplasia: A propensity score-based analysis	4
Hyperglobulinemia predicts increased risk of mortality in primary Sjögren’s syndrome: Based on a Chinese multicentre registry	4
Efficacy of local oxygen–ozone therapy for the treatment of digital ulcer refractory to medical therapy in systemic sclerosis: A randomized controlled study	4
Extension contracture stiff knee in haemophilia: Surgical timing and procedure for total knee arthroplasty	4
Similar short-term KOOS between open-wedge high tibial osteotomy and total knee arthroplasty in patients over age 60: A propensity score–matched cohort study	4
Two distinct subsets of LDGs (low density granulocytes) in ANCA-associated vasculitis	4
Overall survival and post-spontaneous regression relapse-free survival of patients with lymphoproliferative disorders associated with rheumatoid arthritis: a multi-center retrospective cohort study	4
Efficacy and safety of canakinumab for colchicine-resistant or colchicine-intolerant familial Mediterranean fever: A single-centre observational study	4
Therapeutic effect of targeting Substance P on the progression of osteoarthritis	4
Volumetric reduction and dissolution prediction of monosodium urate crystal during urate-lowering therapy – a study using dual-energy computed tomography	4